BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 19482753)

  • 1. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children.
    Glanz JM; McClure DL; Magid DJ; Daley MF; France EK; Salmon DA; Hambidge SJ
    Pediatrics; 2009 Jun; 123(6):1446-51. PubMed ID: 19482753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental refusal of varicella vaccination and the associated risk of varicella infection in children.
    Glanz JM; McClure DL; Magid DJ; Daley MF; France EK; Hambidge SJ
    Arch Pediatr Adolesc Med; 2010 Jan; 164(1):66-70. PubMed ID: 20048244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students.
    Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP
    Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a decline in Colorado Medicaid managed care enrollment on access and quality of preventive primary care services.
    Berman S; Armon C; Todd J
    Pediatrics; 2005 Dec; 116(6):1474-9. PubMed ID: 16322173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy.
    Berger F; Njamkepo E; Minaberry S; Mayet A; Haus-Cheymol R; Verret C; Massit B; Guiso N; Spiegel A
    Vaccine; 2010 Jul; 28(32):5147-52. PubMed ID: 20541009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action to be taken when facing one or more cases of whooping-cough].
    Floret D; Bonmarin I; Deutsch P; Gaudelus J; Grimprel E; Guérin N; Guiso N; Morer I
    Arch Pediatr; 2005 Aug; 12(8):1281-91. PubMed ID: 15961299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
    Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
    Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults.
    Sotir MJ; Cappozzo DL; Warshauer DM; Schmidt CE; Monson TA; Berg JL; Zastrow JA; Gabor GW; Davis JP
    Arch Pediatr Adolesc Med; 2008 Jan; 162(1):79-85. PubMed ID: 18180417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of postvaccinal response in children past pertussis].
    Grzybowska K; Przybyszewski M; Banasik M; Płaneta-Małecka I; Zeman K
    Wiad Lek; 2006; 59(11-12):819-22. PubMed ID: 17427498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella pertussis and Bordetella parapertussis infection in an Austrian pediatric outpatient clinic.
    Frühwirth M; Neher C; Schmidt-Schläpfer G; Allerberger F
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):377-82. PubMed ID: 12708090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].
    de Greeff SC; Schellekens JF; Mooi FR; de Melker HE
    Ned Tijdschr Geneeskd; 2005 Apr; 149(17):937-43. PubMed ID: 15884408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis.
    Purdy KW; Hay JW; Botteman MF; Ward JI
    Clin Infect Dis; 2004 Jul; 39(1):20-8. PubMed ID: 15206048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
    Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
    Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of parental report of influenza vaccination in children 6 to 59 months of age.
    Shinall MC; Plosa EJ; Poehling KA
    Pediatrics; 2007 Oct; 120(4):e783-7. PubMed ID: 17908736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.
    Binkin NJ; Salmaso S; Tozzi AE; Scuderi G; Greco D; Greco D
    Pediatr Infect Dis J; 1992 Aug; 11(8):653-61. PubMed ID: 1523078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.